EZVille, Ltd. of Ronkonkoma, NY, has been informed by the Food and Drug Administration (FDA) that FDA lab analysis of Solo Slim® distributed by the company was found to contain an undeclared drug ingredient. Solo Slim® was found to contain Didesmethyl Sibutramine. Sibutramine is an FDA-approved drug used as an appetite suppressant for weight loss. The FDA has not approved Solo Slim®, therefore the safety and effectiveness of the product is unknown.

Read More...